
By BY PAM BELLUCK from NYT Health Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad. https://ift.tt/2TSOAUm
By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
Hiç yorum yok:
Yorum Gönder